Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
Ladan ZandS Vincent RajkumarNelson R LeungSanjeev SethiMireille El TersFernando C FervenzaPublished in: Journal of the American Society of Nephrology : JASN (2021)
Daratumumab in Treatment of PGNMID and C3 GN, NCT03095118.
Keyphrases